Harvard Bioscience, Inc. announced a significant expansion of its distribution agreement with Fisher Scientific, a part of Thermo Fisher Scientific, to now include the United States. This new agreement complements the existing distribution partnership in Europe, broadening Harvard Bioscience's market access across North America.
Under the expanded agreement, Fisher Scientific will offer Harvard Bioscience's pumps, spectrophotometers, and BTX electroporation systems in the U.S. Critically, this partnership also extends to emerging technologies, including the Mesh MEA (Microelectrode Array) platform, which is designed for advanced organoid research.
This strategic collaboration provides Harvard Bioscience access to hundreds of Fisher Scientific sales representatives, significantly enhancing its sales force and distribution network. The company expects this expansion to improve customer convenience, streamline ordering, accelerate delivery, and provide localized support, thereby accelerating scientific discovery and increasing product adoption.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.